general
Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues
Drug developers Retension Pharmaceuticals and TRex Bio filed their paperwork for U.S. initial public offerings on Friday, reinforcing the biotech pipeline for the fall window.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Badenoch proposes welfare reform that would stop many jobless under-25s getting universal credit – UK politics live
The Guardian UK
UK 30-year borrowing costs hit 6%, highest since 1998, as government bond sell-off intensifies – business live
The Guardian UK
Tributes paid to 'inspirational' presenter and charity founder Esther Rantzen
BBC News
UK house price growth halves amid rising mortgage interest rates
The Guardian UK
Election 2026 live: Minor party leaders go head to head in first big debate of campaign
rnz.co.nz